Active

ADV Pharma

Switched

BE0833723215

Rechtspersoon Private limited company 1 establishment

Route de Quenast 15, 1430 Rebecq Activiteiten van holdings

Active for

15 year, 6 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 426,155

▼ 14% vs 2024

Profit

Healthy

€ 556,412

▼ 24% vs 2024

Debts

Normal

€ 4.7 million

▲ 54% vs 2024

ADV Pharma from Rebecq, company number BE0833723215, closed financial year 2025 with a result of € 556,412 after tax. For that financial year ADV Pharma recorded a gross margin of € 426,155 and equity of € 2.5 million. Compared with financial year 2024, the result moved from € 729,691 to € 556,412. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What happened at ADV Pharma?

What happened at ADV Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 556,412 (▼ 24% vs 2024). Source: NBB ↗
  • MCGD SNC became a director. NBB
  • FJA SNC became a director. NBB
  • New establishment in Pont-à-Celles. KBO
  • Start of the company according to the CBE. KBO

In short

From € 687,617 profit in 2021 to € 556,412 profit in 2025.

Paid € 176,131 in corporate taxes since 2021.

Best year ever: 2024, with € 729,691 profit.

Paid out € 2.3 million in dividends to the owners in total.

A new publication or filing at ADV Pharma? We notify you, reason included.

Follow ADV Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind ADV Pharma are MCGD SNC and FJA SNC. It owns 100% of Medi-Prest SA, 100% of La Pharmacie De Vriese SPRL, 100% of La Pharmacie de Saintes SPRL and 100% of Bauphar SA itself.

See the full network in the app

Directors

According to the 2025 annual accounts

MCGD SNC

Director · represented by CAROLINE DE VRIESE

since 2014

FJA SNC

Director · represented by ALINE DE VRIESE

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Route de Quenast 15

1430 Rebecq

2.196.610.035

Rue Liberté(PAC) 56

6230 Pont-à-Celles

Active since 14 February 2011

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0833.723.215
VAT number
BE 0833.723.215
Registered office
Route de Quenast 15, 1430 Rebecq
Names & denominations
ADV Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
14 February 2011
Peppol
Active · Active since 9 Dec 2025
Activities · NACE

Activiteiten van holdings

Holdings

Detailhandel in farmaceutische producten

Frequently asked questions

What is the enterprise number of ADV Pharma?
The enterprise number of ADV Pharma is BE0833723215.
What is the address of ADV Pharma?
The registered office of ADV Pharma is located at Route de Quenast 15, 1430 Rebecq.
When was ADV Pharma founded?
ADV Pharma was founded on 14 February 2011.
What is the main activity of ADV Pharma?
The main activity of ADV Pharma is "Activiteiten van holdings" (NACE code 64210).
Does ADV Pharma have a website?
No website is currently known for ADV Pharma.
How much profit did ADV Pharma make in 2025?
ADV Pharma posted a profit after taxes of € 556,412 in financial year 2025.
What is the revenue of ADV Pharma?
As a small company, ADV Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 426,155.
Where can I find the annual accounts of ADV Pharma?
ADV Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of ADV Pharma?
According to the 2025 annual accounts, the directors of ADV Pharma are: MCGD SNC, FJA SNC.
Who owns ADV Pharma?
Behind ADV Pharma are MCGD SNC and FJA SNC. It owns 100% of Medi-Prest SA, 100% of La Pharmacie De Vriese SPRL, 100% of La Pharmacie de Saintes SPRL and 100% of Bauphar SA itself.